Intelligent Bio Solutions (INBS) Debt to Equity (2020 - 2024)

Intelligent Bio Solutions' Debt to Equity history runs 5 years deep, the most recent figure standing at $0.01 for Q1 2024.

• In Q1 2024, Debt to Equity fell 82.78% year-over-year to $0.01; the TTM figure through Mar 2024 stood at $0.01 (down 82.78% YoY), while the FY2023 annual figure was $0.11, down 74.79% from the prior year.
• Debt to Equity was $0.01 for Q1 2024 at Intelligent Bio Solutions, down from $0.07 in the prior quarter.
• In the past five years, Debt to Equity ranged from a high of $0.43 in Q2 2022 to a low of -$0.34 in Q2 2020.
• Historically, Debt to Equity has averaged $0.06 across 5 years, with a median of $0.04 in 2020.
• The sharpest annual moves came in 2021 and 2022: Debt to Equity sank 95.87% in 2021, then surged 48710.75% in 2022.
• A 5-year view of Debt to Equity shows it stood at $0.02 in 2020, then tumbled by 95.87% to $0.0 in 2021, then soared by 5107.82% to $0.05 in 2022, then jumped by 48.11% to $0.07 in 2023, then plunged by 81.32% to $0.01 in 2024.
• The last three Debt to Equity figures came in at $0.01 (Q1 2024), $0.07 (Q4 2023), and $0.25 (Q3 2023), per Business Quant data.